News & Articles
Selected Filters:
Beckman Coulter Life Sciences launches next-generation CytoFLEX SRT Benchtop Cell Sorter
Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process
Natera and Personalis partner for personalized monitoring in oncology
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
FDA grants emergency use authorization for home collection kit for Advanta Dx SARS-CoV-2 RT-PCR assay
Collaboration agreement to market AZOVA COVID-19 test collection kit online
SARS-CoV-2 mutations in competition
Novel pooled testing strategies can significantly increase ability to identify COVID-19 infections
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
High fructose diets could cause immune system damage
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
Global taskforce set to demystify and overcome vaccine hesitancy amid COVID-19 pandemic
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
Beckman Coulter Life Sciences established as first US distributor of genedrive plc COVID-19 kit
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Agilent PD-L1 IHC 22C3 pharmDx receives expanded FDA approval in non-small cell lung cancer
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Ananda Devices, Molecular Devices collaborate to automate imaging and customize analysis of nervous system on-a-chip
Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System
AstraZeneca COVID-19 vaccine authorized for emergency use by World Health Organization
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Pre Diagnostics completes proof of concept study for its intracellular PreADx immunoassay for detection of Alzheimer’s Disease
Focusing on innate immunity opens way for precision medicine approaches to AD
PerkinElmer changes COVID-19 rapid testing landscape with highly sensitive point of care antigen test for mass screening
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Don't miss out on these 6 new expert webinars
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Cancer researchers assess microsatellite instability through a new lens with expanded Promega system
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
New resources to advance your COVID-19 research
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Discover how to profile host responses in COVID-19 patients with ELLA SimplePlex
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
The importance of pediatric reference intervals for diagnostic testing
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
George Mason University employs rapid-result COVID-19 tests to control the spread of virus on campus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
Pfizer and IDA Foundation partner to expand access to essential cancer treatments low-and middle-income countries
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
Avacta Group partners with Mologic to market SARS-CoV-2 lateral flow rapid antigen test
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing























